Kiran Mazumdar-Shaw
Insider Reports History
- Location
- Boston, MA
- Signature
- /s/ Lara Meisner, Attorney-in-Fact
- All insider transactions
- Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date
Holdings reported by Kiran Mazumdar-Shaw:
| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Bicara Therapeutics Inc. | Director, 10%+ Owner | Common Stock | 4,443,122 | $58,842,042 | $13.24 | 16 Sep 2024 | By Biocon Limited |
| Bicara Therapeutics Inc. | Director, 10%+ Owner | Common Stock | 1,080,775 | $14,313,136 | $13.24 | 16 Sep 2024 | By Biocon Pharma Inc. |
| Bicara Therapeutics Inc. | Director, 10%+ Owner | Common Stock | 432,736 | $5,730,896 | $13.24 | 16 Sep 2024 | By Carica Investments |
| Bicara Therapeutics Inc. | Director, 10%+ Owner | Common Stock | 324,552 | $4,298,172 | $13.24 | 16 Sep 2024 | By Glentech International |
| Bicara Therapeutics Inc. | Director, 10%+ Owner | Stock Option (Right to Buy) | 23,746 | 09 Jun 2025 | Direct | ||
| Bicara Therapeutics Inc. | Director, 10%+ Owner | Series Seed Redeemable Convertible Preferred Stock | 0 | 16 Sep 2024 | By Biocon Limited | ||
| Bicara Therapeutics Inc. | Director, 10%+ Owner | Series Seed Redeemable Convertible Preferred Stock | 0 | 16 Sep 2024 | By Biocon Pharma Inc. | ||
| Bicara Therapeutics Inc. | Director, 10%+ Owner | Series Seed Redeemable Convertible Preferred Stock | 0 | 16 Sep 2024 | By Carica Investments | ||
| Bicara Therapeutics Inc. | Director, 10%+ Owner | Series Seed Redeemable Convertible Preferred Stock | 0 | 16 Sep 2024 | By Glentech International |
Insider Reports Filed by Kiran Mazumdar-Shaw
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| BCAX | Bicara Therapeutics Inc. | 09 Jun 2025 | 1 | $0 | 4 | Director, 10%+ Owner | 10 Jun 2025, 16:31 |
| BCAX | Bicara Therapeutics Inc. | 12 Sep 2024 | 9 | $0 | 4 | Director, 10%+ Owner | 16 Sep 2024, 16:35 |
| BCAX | Bicara Therapeutics Inc. | 12 Sep 2024 | 0 | $0 | 3 | Director, 10%+ Owner | 12 Sep 2024, 21:11 |